Lu AF82422 is often a mAb demonstrated as Secure and very well tolerated inside of a phase I trial in healthful topics and people with PD (NCT03611569). A phase II analyze investigating the safety and efficacy in https://ksnr.org.in/multiple-system-atrophy/